Ankush Gosain1,2, Philip K Frykman3, Robert A Cowles4, John Horton5, Marc Levitt6,7, David H Rothstein8, Jacob C Langer9, Allan M Goldstein10. 1. Division of Pediatric Surgery, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA. agosain@uthsc.edu. 2. Children's Foundation Research Institute, Le Bonheur Children's Hospital, 50 North Dunlap, Suite 320R, Memphis, TN, 38,105, USA. agosain@uthsc.edu. 3. Division of Pediatric Surgery and Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 4. Section of Pediatric Surgery, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. 5. Madigan Army Medical Center, Tacoma, WA, USA. 6. Center for Colorectal and Pelvic Reconstruction, Nationwide Children's Hospital, Columbus, OH, USA. 7. Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, USA. 8. Department of Pediatric Surgery, Women and Children's Hospital of Buffalo, Buffalo, NY, USA. 9. Division of General and Thoracic Surgery, Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Canada. 10. Department of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Warren 1151, Boston, MA, 02114, USA. agoldstein@partners.org.
Abstract
BACKGROUND: Patients with Hirschsprung disease are at risk for Hirschsprung-associated enterocolitis (HAEC), an inflammatory disorder of the bowel that represents the leading cause of serious morbidity and death in these patients. The diagnosis of HAEC is made based on clinical signs and symptoms which are often non-specific, making it difficult to establish a definitive diagnosis in many patients. The purpose of this guideline is to present a rational, expert-based approach to the diagnosis and management of HAEC. METHODS: The American Pediatric Surgical Association Board of Governors established a Hirschsprung Disease Interest Group. Group discussions, literature review, and expert consensus were then used to summarize the current state of knowledge regarding diagnosis, management, and prevention of Hirschsprung-associated enterocolitis (HAEC). RESULTS: Guidelines for the diagnosis of HAEC and its clinical grade, utilizing clinical history, physical examination findings, and radiographic findings, are presented. Treatment guidelines, including patient disposition, diet, antibiotics, rectal irrigations and surgery, are presented. CONCLUSIONS: Clear, standardized definitions of Hirschsprung-associated enterocolitis and its treatment are lacking in the literature. This guideline serves as a first step toward standardization of diagnosis and management. LEVEL OF EVIDENCE: V.
BACKGROUND:Patients with Hirschsprung disease are at risk for Hirschsprung-associated enterocolitis (HAEC), an inflammatory disorder of the bowel that represents the leading cause of serious morbidity and death in these patients. The diagnosis of HAEC is made based on clinical signs and symptoms which are often non-specific, making it difficult to establish a definitive diagnosis in many patients. The purpose of this guideline is to present a rational, expert-based approach to the diagnosis and management of HAEC. METHODS: The American Pediatric Surgical Association Board of Governors established a Hirschsprung Disease Interest Group. Group discussions, literature review, and expert consensus were then used to summarize the current state of knowledge regarding diagnosis, management, and prevention of Hirschsprung-associated enterocolitis (HAEC). RESULTS: Guidelines for the diagnosis of HAEC and its clinical grade, utilizing clinical history, physical examination findings, and radiographic findings, are presented. Treatment guidelines, including patient disposition, diet, antibiotics, rectal irrigations and surgery, are presented. CONCLUSIONS: Clear, standardized definitions of Hirschsprung-associated enterocolitis and its treatment are lacking in the literature. This guideline serves as a first step toward standardization of diagnosis and management. LEVEL OF EVIDENCE: V.
Authors: Zhilong Yan; Valeriy Poroyko; Song Gu; Zheng Zhang; Liya Pan; Jing Wang; Nan Bao; Li Hong Journal: Biochem Biophys Res Commun Date: 2014-02-10 Impact factor: 3.575
Authors: Ankush Gosain; Amanda J Barlow-Anacker; Chris S Erickson; Joseph F Pierre; Aaron F Heneghan; Miles L Epstein; Kenneth A Kudsk Journal: PLoS One Date: 2015-06-10 Impact factor: 3.240
Authors: Philip K Frykman; Agneta Nordenskjöld; Akemi Kawaguchi; Thomas T Hui; Anna L Granström; Zhi Cheng; Jie Tang; David M Underhill; Iliyan Iliev; Vince A Funari; Tomas Wester Journal: PLoS One Date: 2015-04-24 Impact factor: 3.240
Authors: Daniëlle Roorda; Tessa J Surridge; Ruben G J Visschers; Joep P M Derikx; L W Ernest van Heurn Journal: Int J Colorectal Dis Date: 2019-10-19 Impact factor: 2.571
Authors: Ruth A Lewit; Laura V Veras; Robert A Cowles; Kathryn Fowler; Sebastian King; Eveline Lapidus-Krol; Jacob C Langer; Christine J Park; Fouad Youssef; Sergey Vavilov; Ankush Gosain Journal: J Surg Res Date: 2021-01-15 Impact factor: 2.192